Jamie Gabel is a Physician Assistant, Co-Founder and Clinical Director for Advitam (ad-vee-tum) at the Shafer Clinic in New York City. Jamie started his career in sports medicine and orthopedic surgery and became interested in regenerative medicine which propelled his journey into cellular and metabolic medicine. As a Fellow of the “Seeds Scientific Research and Performance Institute”, Jamie stays current on the latest research and advancements in cellular medicine.
Article
Dec 10, 2025
Jamie Gabel
Myriah Werne
RELATED RESOURCES
Continue exploring related topics.
VIEW ALLVIDEO
Cellular Medicine Mondays
Jul 6, 2026
Ep. 095 - Dr. Seeds’ Office Hours
Preview Only
Dr. Seeds’ Office Hours – Episode 095
Dr. Seeds’ Office Hours – Episode 095
1. Sjögren’s, POTS, Mold, Biofilms & Lumbrokinase (0:45)
2. PMDD, Allopregnanolone & Mitochondrial Efficiency (7:28)
3. Retatrutide, Glucagon & Metabolic Flexibility (20:01)
Preview Only — Become a member for full access
Scott Sherr, MD
Jul 2, 2026
Methylene Blue: From Cellular Energy to Clinical Practice
Scott Sherr, MD | LucÃa González Forte, PhD Submitted for publication [Article] to the SSRP Institute Abstract Methylene blue (MB) is a century-old compound whose renewed relevance in clinical medicine reflects a clearer understanding of its role in mitochondrial function, redox biology, and neuroinflammatory signaling. At therapeutic oral doses, MB acts as a catalytic electron […]
READ ARTICLE
Foundational
Foundational
The Self-Led Woman
If you are in midlife and feel like your body stopped following the rules it used to, this course is for you. The premise is simple: your body is not broken. It is running a different program than the one...
9 Lessons
1 Hour 28 Minutes
VIDEO
Cellular Medicine Mondays
Jun 29, 2026
Ep. 094 - Cellular Optimization for EDS Surgical Support
Preview Only
Dissecting Protocols – Episode 094
Cellular Optimization for EDS Surgical Support
Dr. Seeds reviews peptide and supplemental considerations for cellular optimization in an EDS patient preparing for orthopedic surgery. (Question Link)
Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Jun 22, 2026
Ep. 093 - The Phosphatidylcholine Pathway
Preview Only
Rabbit Holes – Episode 093
The Phosphatidylcholine Pathway
Dr. Seeds expands on Journal Club Episode 92 to explore the role of phosphatidylcholine in lipid metabolism, methylation, and mitochondrial integrity during aging. He also highlights how estrogen loss may impact this pathway, especially in pre- and post-menopausal women.
Preview Only — Become a member for full access
Pathways
Pathways
The Cell Code
A Cellular Medicine Perspective on Health, Aging, and Disease Cell Code is a structured walk through ten core molecular pathways that shape Cellular Medicine. For each pathway, the course presents twenty questions, beginning with foundational mechanisms and moving into applied...
31 Lessons
Self-paced
VIDEO
Cellular Medicine Mondays
Jun 15, 2026
Ep. 092 - Aging-Associated Decline of Phosphatidylcholine Synthesis is a Malleable Trigger of Natural Mitochondrial Aging
Preview Only
Journal Club – Episode 092
Aging-Associated Decline of Phosphatidylcholine Synthesis is a Malleable Trigger of Natural Mitochondrial Aging
Dr. Seeds explores how age-related decline in phosphatidylcholine synthesis may contribute to mitochondrial aging and why that matters in Cellular Medicine. This discussion connects membrane integrity, mitochondrial function, methylation, and metabolic resilience, while highlighting how this pathway may be more modifiable than we once thought.
Preview Only — Become a member for full access
SSRP Institute
Jun 10, 2026
PCOS Name Change to PMOS: Polyendocrine Metabolic Ovarian Syndrome
HEADLINE SCIENCE An international body of medical scientists in obstetrics and gynecology, endocrinology, and other speciality societies, and other physicians announced the result of a multi-year process to formally change the name of Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This change, published in May 2026 in The Lancet, aims to address […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Jun 8, 2026
Ep. 091 - Dr. Seeds’ Office Hours
Preview Only
Dr. Seeds’ Office Hours – Episode 091
1. Managing shingles outbreaks in GLP-1 patient through peptides (0:40)
2. Peptide strategies in suspected ALS (15:56)
3. Improving durability in dementia treatment (25:08)
Preview Only — Become a member for full access
William Seeds, MD
Jun 3, 2026
GLP-1 and the Gut–Musculoskeletal Axis: A Clinical Summary
The Overlooked Connection: Dysbiosis and Degenerative Disease Degenerative musculoskeletal diseases, including osteoarthritis (OA), osteoporosis (OP), sarcopenia (SP), and intervertebral disc degeneration (IVDD), affect well over a billion people globally and share three core pathological features: chronic inflammation, oxidative stress, and dysregulated cell death. What is increasingly clear, and clinically underappreciated, is that gut microbiota (GM) […]
READ ARTICLE